Results 71 to 80 of about 1,944,029 (193)

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions

open access: yesFuture Journal of Pharmaceutical Sciences, 2020
Background The resistance of V600E-BRAF to the vemurafenib and the side effects of the identified inhibitors trigger the research for a novel and more potent anti-melanoma agents. In this study, virtual docking screening along with pharmacokinetics ADMET
Abdullahi Bello Umar   +3 more
doaj   +1 more source

On the Origins of Three-Dimensionality in Drug-Like Molecules [PDF]

open access: yesFuture Medicinal Chemistry, 2016
Many medicinal chemistry-relevant structures and core scaffolds tend toward geometric planarity, which hampers the optimization of physicochemical properties desirable in drug-like molecules. As challenging drug target classes emerge, the exploitation of molecular three-dimensionality in lead optimization is becoming increasingly important.
Meyers, J, Carter, M, Mok, NY, Brown, N
openaire   +3 more sources

GPT like transformer based conditional molecule generator and a high drug-likeness (QED) dataset generation [PDF]

open access: yes
This study presents the development and evaluation of a novel GPT-like conditional molecule generator designed to optimize the synthesis of chemical compounds with desirable properties.
Juan , Yang, Wen, Xing
core   +1 more source

Molecular docking and prediction of ADME/drug-likeness properties of potentially active antidiabetic compounds isolated from aqueous-methanol extracts of Gymnema sylvestre and Combretum micranthum [PDF]

open access: yes, 2021
Gymnema sylvestre and Combretum micranthum are well known for their ethno-medicinal uses in the northwest of Nigeria. In our recent study, we demonstrated the antidiabetic and antioxidant activities of the aqueous-me¬thanol extracts of the two plants and
Ononamadu, C.J.   +3 more
core   +1 more source

New antimalarial hits from Dacryodes edulis (Burseraceae)--part I: isolation, in vitro activity, in silico "drug-likeness" and pharmacokinetic profiles. [PDF]

open access: yesPLoS ONE, 2013
The aims of the present study were to identify the compounds responsible for the anti-malarial activity of Dacryoedes edulis (Burseraceae) and to investigate their suitability as leads for the treatment of drug resistant malaria.
Denis Zofou   +6 more
doaj   +1 more source

Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors

open access: yesEgyptian Journal of Medical Human Genetics, 2020
Background V600E-BRAF is a major protein target involved in various types of human cancers. However, the acquired resistance of the V600E-BRAF kinase to the vemurafenib and the side effects of other identified drugs initiate the search for efficient ...
Abdullahi Bello Umar   +3 more
doaj   +1 more source

Drug-likeness evaluation of the six dual-active alkaloids.

open access: yes
Drug-likeness evaluation of the six dual-active alkaloids.
Iqra Ahmad (17471892)   +11 more
core   +1 more source

Natural product-likeness score revisited: an open-source, open-data implementation

open access: yesBMC Bioinformatics, 2012
Background Natural product-likeness of a molecule, i.e. similarity of this molecule to the structure space covered by natural products, is a useful criterion in screening compound libraries and in designing new lead compounds.
Jayaseelan Kalai Vanii   +4 more
doaj   +1 more source

Drug-likeness (Lipinski rule of five) for XL765 and the six proposed dual inhibitors 28, 18, 38, 9, 10, and 19.

open access: yes, 2019
Drug-likeness (Lipinski rule of five) for XL765 and the six proposed dual inhibitors 28, 18, 38, 9, 10, and 19.
Mohd Rehan (198120)
core   +1 more source

Lipinski’s rule of five and Veber’s rule for drug-likeness analysis of selected phytochemicals and small molecule drugs.

open access: yes, 2022
Lipinski’s rule of five and Veber’s rule for drug-likeness analysis of selected phytochemicals and small molecule drugs.
Lemessa Etana Bultum (13162800)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy